SCHEMBL4758833

SCHEMBL4758833

COC(=O)c1cc(N)c(C(=O)OC)cc1N

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.73
▸ ALDH1A1 P00352 6/20 0.64
▸ GAA P10253 6/20 0.64
▸ HSD17B10 Q99714 3/20 0.64
▸ MAPT P10636 3/20 0.64
▸ HPGD P15428 3/20 0.64
▸ GLA P06280 2/20 0.64
▸ CASP1 P29466 1/20 0.64
▸ CASP7 P55210 1/20 0.64
▸ ATM Q13315 1/20 0.64
▸ ABL1 P00519 1/20 0.62
▸ TSHR P16473 3/20 0.60
▸ ALOX15 P16050 1/20 0.60
▸ CFTR P13569 5/20 0.59
▸ POLB P06746 1/20 0.50
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA7 P43166 2/20 0.47
▸ CA9 Q16790 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5692887 0.93 KDM4E (0.70) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL11685663 0.91 KDM4E (0.63) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL22535980 0.90 KDM4E (0.61) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2897750 0.89 KDM4E (0.61) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL1567667 0.88 KDM4E (0.59) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL28922445 0.88 CFTR (0.66) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2900514 0.88 KDM4E (0.59) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2900351 0.88 KDM4E (0.82) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2897626 0.88 GAA (0.62) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2701033 0.87 GAA (0.61) KDM4EALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118063325-A Method for synthesizing 1,2,4, 5-tetraaminobenzene hydrochloride 常州大学 2024-05-24 — — CN claimed
EP-4717249-A1 DENTAL COMPOSITION Shofu Inc. (JP) 2026-04-01 — — EP disclosed
US-20260083642-A1 DENTAL COMPOSITION SHOFU INC (JP) 2026-03-26 — — US disclosed
CN-119074563-A Dental curable composition containing ultraviolet absorber 株式会社松风 2024-12-06 — — CN disclosed
CN-118079661-A Two-dimensional porous frame-based mixed matrix membrane, and preparation method and separation application thereof 中国科学院大连化学物理研究所 2024-05-28 — — CN disclosed
CN-118063325-A Method for synthesizing 1,2,4, 5-tetraaminobenzene hydrochloride 常州大学 2024-05-24 — — CN disclosed
CN-118063325-A Method for synthesizing 1,2,4, 5-tetraaminobenzene hydrochloride 常州大学 2024-05-24 — — CN disclosed
US-20220047465-A1 DENTAL COMPOSITION GC CORPORATION (JP) 2022-02-17 — — US disclosed
EP-3858322-A1 DENTAL COMPOSITION GC Corporation (JP) 2021-08-04 — — EP disclosed
JP-2008127321-A METHOD FOR PRODUCING DIGLYCYLTEREPHTHALIC ACID COMPOUND TOYOBO CO LTD 2008-06-05 — — JP disclosed
US-4046755-A CELLULOSE ETHERS, POLYAMIDES, POLYURETHANES, ACRYLICS CIBA-GEIGY CORPORATION (US) 1977-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220047465-A1 DENTAL COMPOSITION TAS2R45, TAS2R40, TAS2R42 KDM4E 825/4885ALDH1A1 167/4885GAA 3122/4885
US-20260083642-A1 DENTAL COMPOSITION TAS2R42, COL2A1, TAS2R1 KDM4E 3950/4885ALDH1A1 1319/4885GAA 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback